---
title: "Dr.Datsons Labs Ltd (DRDATSONS) — Share Price, Financials & Analysis"
symbol: "DRDATSONS"
company: "Dr.Datsons Labs Ltd"
canonical: "https://tapetide.com/stocks/DRDATSONS"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:40:16.475Z"
---

# Dr.Datsons Labs Ltd (DRDATSONS)

Canonical page: https://tapetide.com/stocks/DRDATSONS

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** drdatsons.com

## About

Dr.Datsons Labs Ltd is an India-based integrated pharmaceutical company. The company is engaged in the manufacturing and marketing capabilities in contract research and manufacturing services, and active pharmaceutical ingredients.

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Stock is trading at 0.13 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of 9.06% over last 3 years.
- Earnings include an other income of Rs.17.1 Cr.
- Dividend payout has been low at 8.42% of profits over last 3 years
- Company has high debtors of 317 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -144% | -74% | -33% |
| revenue growth | 7% | 10% | 36% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2009 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 30.87 | 73.91 | 117.69 | 132 | 150.57 | 20.79 | 201.44 | 114.03 | 171.12 |
| Expenses | 25.39 | 67.7 | 96.9 | 114.99 | 130 | 22.11 | 191.42 | 108.43 | 165.9 |
| Operating Profit | 5.48 | 6.21 | 20.79 | 17.01 | 20.57 | -1.32 | 10.02 | 5.6 | 5.22 |
| OPM % | 17.75 | 8.4 | 17.67 | 12.89 | 13.66 | -6.35 | 4.97 | 4.91 | 3.05 |
| Other Income | 0 | -45.41 | 0 | -0.14 | 0 | 7.83 | 0 | 4.37 | 4.92 |
| Interest | 1.16 | 9.93 | 11.74 | 8.31 | 12.67 | 10.29 | 8.69 | 8.68 | 8.85 |
| Depreciation | 0.2 | 5.42 | 5.1 | 5.15 | 5.15 | 5.04 | 1.25 | 1.26 | 1.26 |
| Profit before tax | 4.12 | -54.55 | 3.95 | 3.41 | 2.75 | -8.82 | 0.08 | 0.03 | 0.03 |
| Tax % | 30.1 | -30.03 | 18.23 | 48.97 | 32.36 | -30.27 | 37.5 | 33.33 | 33.33 |
| Net Profit | 2.88 | -38.17 | 3.24 | 1.74 | 1.86 | -6.15 | 0.06 | 0.02 | 0.02 |
| EPS in Rs | — | -27.49 | 2.33 | 1.25 | 1.34 | -1.94 | 0.01 | 0 | 0 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 15m | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 22 | 90 | 162 | 320 | 480 | 521 | 421 | 507 |
| Expenses | 0 | 17 | 79 | 132 | 250 | 375 | 415 | 364 | 488 |
| Operating Profit | 0 | 5 | 11 | 29 | 71 | 105 | 106 | 57 | 20 |
| OPM % | — | 22 | 12 | 18 | 22 | 22 | 20 | 14 | 3.9 |
| Other Income | 0 | 0 | 0 | 1 | 0 | 2 | -40 | 8 | 17 |
| Interest | 0 | 1 | 3 | 6 | 14 | 29 | 43 | 43 | 37 |
| Depreciation | 0 | 0 | 1 | 1 | 3 | 16 | 20 | 20 | 9 |
| Profit before tax | 0 | 4 | 8 | 23 | 55 | 63 | 3 | 1 | -9 |
| Tax % | — | 37 | 35 | 34 | 34 | 35 | 80 | 48 | — |
| Net Profit | 0 | 2 | 5 | 15 | 36 | 41 | 1 | 1 | -6 |
| EPS in Rs | — | — | — | — | — | 29.55 | 0.4 | 0.21 | -1.93 |
| Dividend Payout % | — | 0 | 0 | 0 | 0 | 0 | 25 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Sep 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 2 | 5 | 6 | 8 | 14 | 14 | 32 | 53 |
| Reserves | 0 | 2 | 7 | 44 | 127 | 336 | 296 | 376 | 475 |
| Borrowings | 1 | 12 | 38 | 60 | 139 | 299 | 550 | 495 | 366 |
| Other Liabilities | 0 | 11 | 11 | 25 | 22 | 70 | 186 | 360 | 164 |
| Total Liabilities | 1 | 28 | 61 | 135 | 295 | 718 | 1045 | 1263 | 1058 |
| Fixed Assets | 0 | 11 | 13 | 47 | 70 | 214 | 208 | 188 | 186 |
| CWIP | 1 | 0 | 0 | 4 | 47 | 144 | 164 | 179 | 343 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 213 | 213 |
| Other Assets | 0 | 17 | 47 | 84 | 178 | 359 | 670 | 683 | 316 |
| Total Assets | 1 | 28 | 61 | 135 | 295 | 718 | 1045 | 1263 | 1058 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | -2 | -22 | 1 | -46 | -46 | 40 | 135 |
| Cash from Investing Activity | -1 | -11 | -3 | -39 | -68 | -256 | -36 | -226 |
| Cash from Financing Activity | 1 | 13 | 26 | 38 | 114 | 305 | 205 | -120 |
| Net Cash Flow | 0 | 0 | 1 | 0 | 0 | 3 | 208 | -211 |
| Free Cash Flow | -1 | -13 | -25 | -38 | -114 | -303 | 5 | 119 |
| CFO/OP | — | -50 | -196 | 10 | -62 | -24 | 39 | 237 |

### Ratios

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 205 | 125 | 98 | 103 | 153 | 191 | 317 |
| Inventory Days | — | 63 | 76 | 107 | 129 | 142 | 157 | 194 |
| Days Payable | — | 0 | 0 | 46 | -9 | 41 | 150 | 326 |
| Cash Conversion Cycle | — | 269 | 201 | 158 | 242 | 253 | 198 | 185 |
| Working Capital Days | — | 110 | 150 | 135 | 183 | 228 | 202 | 293 |
| ROCE % | — | 52 | 31 | 36 | 36 | 20 | 12 | 5 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 17.81 | Sell |
| EMA (10) | 17.7 | Sell |
| SMA (20) | 18.34 | Sell |
| EMA (20) | 18.13 | Sell |
| SMA (50) | 18.87 | Sell |
| EMA (50) | 18.8 | Sell |
| SMA (100) | 19.74 | Sell |
| EMA (100) | 19.5 | Sell |
| SMA (200) | 20.53 | Sell |
| EMA (200) | 20.33 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 38.83 | Neutral |
| MACD (12,26,9) | -0.5 | Sell |
| Stochastic (14,3,3) | 29.07 | Neutral |
| ADX (14) | 9.77 | Neutral |
| Williams %R (14) | -66.48 | Neutral |
| ATR (14) | 1.3 | High Volatility |
| ROC (12) | -7.59 | Sell |
| Stoch RSI (14) | 62.57 | Neutral |
| UO (7,14,28) | 34.12 | Neutral |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2014 from bse](http://www.bseindia.com/bseplus/AnnualReport/533412/5334120314.pdf) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport//5334120313.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport//5334120312.PDF) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport//5334120311.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:40:16.475Z.